Follows adults with severe obesity after an endoscopic stomach-shaping procedure
Records outcomes in adults with morbid obesity after endoscopic gastric tubulization.
Plain-language title generated from the registry record
Registry title: Endoscopic Gastric Tubulization
Key facts
- Where
- Strasbourg, FranceSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with morbid obesity who are scheduled for an endoscopic gastric tubulization at the Nouvel Hôpital Civil in Strasbourg, France.
- Age
- 18 to 65 years
- Sex
- Men and women can join.
- Disease stage
- Morbid obesity.
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT03554902, who can take part
Where in France
- Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital CivilStrasbourg, FranceContact: Silvana Perretta, MD, PhDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- IHU Strasbourg
- Trial code
- NCT03554902
- Record updated
- 1 May 2025
- Original description
Endoscopic gastric tubulization is currently proposed in the Digestive Surgery Department of the Nouvel Hôpital Civil, Strasbourg, France, to adult patients with morbid obesity. The procedure is performed using the CE marked endoscopic suture device Overstitch (Apollo Endosurgery, Austin, Tx. USA). It is standard practice since October 2016.Read full original descriptionShow less
Endoscopic Gastric Tubulization
Endoscopic gastric tubulization is currently proposed in the Digestive Surgery Department of the Nouvel Hôpital Civil, Strasbourg, France, to adult patients with morbid obesity. The procedure is performed using the CE marked endoscopic suture device Overstitch (Apollo Endosurgery, Austin, Tx. USA). It is standard practice since October 2016.
The objective of this study is to prospectively collect data of patients who underwent an endoscopic gastric tubulization, from last visit before procedure to 2 years after procedure. These data are usually collected during medical consultations and will enable the evaluation of weight loss, quality of life and comorbidities improvement, reproducibility and durability of the technique.
Inclusion: Patients scheduled for an endoscopic gastric tubulization in the Nouvel Hôpital Civil, Strasbourg, France.